Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000882796-06-000019
Filing Date
2006-05-05
Accepted
2006-05-05 16:26:47
Documents
1
Period of Report
2006-05-03

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT doc.html 4  
1 PRIMARY DOCUMENT doc.xml 4 14654
  Complete submission text file 0000882796-06-000019.txt   16494
Mailing Address 2190 PARKWAY LAKE DR BIRMINGHAM AL 35244
Business Address 2190 PARKWAY LAKE DR BIRMINGHAM AL 35244 2054444600
BIOCRYST PHARMACEUTICALS INC (Issuer) CIK: 0000882796 (see all company filings)

EIN.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1220
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O BIOCRYST PHARMACEUTICALS, INC 2190 PKWY LAKE DRIVE BIRMINGHAM AL 35244
Business Address 2054444600
BENNETT J CLAUDE (Reporting) CIK: 0001198766 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-23186 | Film No.: 06813407